Literature DB >> 33412118

Overdiagnosis in lung cancer screening.

Matthew E J Callister1, Peter Sasieni2, Hilary A Robbins3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33412118      PMCID： PMC8021885          DOI： 10.1016/S2213-2600(20)30553-1

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  16 in total

1.  Lung Cancer Screening in a Safety-Net Hospital: Implications of Screening a Real-World Population versus the National Lung Screening Trial.

Authors:  Jonathan M Iaccarino; Katrina A Steiling; Renda Soylemez Wiener
Journal:  Ann Am Thorac Soc       Date:  2018-12

2.  Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates.

Authors:  Erik F Blom; Kevin Ten Haaf; Harry J de Koning
Journal:  Lung Cancer       Date:  2019-11-28       Impact factor: 5.705

3.  Implementation of targeted screening for lung cancer in a high-risk population within routine NHS practice using low-dose computed tomography.

Authors:  Helen Grover; Thomas Ross; Elizabeth Fuller
Journal:  Thorax       Date:  2020-03-03       Impact factor: 9.139

4.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

5.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.

Authors:  Harry J de Koning; Carlijn M van der Aalst; Pim A de Jong; Ernst T Scholten; Kristiaan Nackaerts; Marjolein A Heuvelmans; Jan-Willem J Lammers; Carla Weenink; Uraujh Yousaf-Khan; Nanda Horeweg; Susan van 't Westeinde; Mathias Prokop; Willem P Mali; Firdaus A A Mohamed Hoesein; Peter M A van Ooijen; Joachim G J V Aerts; Michael A den Bakker; Erik Thunnissen; Johny Verschakelen; Rozemarijn Vliegenthart; Joan E Walter; Kevin Ten Haaf; Harry J M Groen; Matthijs Oudkerk
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 91.245

6.  Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.

Authors:  Nichole T Tanner; Lin Dai; Brett C Bade; Mulugeta Gebregziabher; Gerard A Silvestri
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

7.  Baseline characteristics of participants in the randomized national lung screening trial.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; Jonathan D Clapp; Kathy L Clingan; Ilana F Gareen; David A Lynch; Pamela M Marcus; Paul F Pinsky
Journal:  J Natl Cancer Inst       Date:  2010-11-22       Impact factor: 13.506

8.  Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement.

Authors:  M Patricia Rivera; Nichole T Tanner; Gerard A Silvestri; Frank C Detterbeck; Martin C Tammemägi; Robert P Young; Christopher G Slatore; Tanner J Caverly; Cynthia M Boyd; Dejana Braithwaite; Joelle T Fathi; Michael K Gould; Jonathan M Iaccarino; Stephen P Malkoski; Peter J Mazzone; Lynn T Tanoue; Nancy L Schoenborn; Javier J Zulueta; Renda Soylemez Wiener
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

9.  Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.

Authors:  Phil A Crosbie; Haval Balata; Matthew Evison; Melanie Atack; Val Bayliss-Brideaux; Denis Colligan; Rebecca Duerden; Josephine Eaglesfield; Timothy Edwards; Peter Elton; Julie Foster; Melanie Greaves; Graham Hayler; Coral Higgins; John Howells; Klaus Irion; Devinda Karunaratne; Jodie Kelly; Zoe King; Judith Lyons; Sarah Manson; Stuart Mellor; Donna Miller; Amanda Myerscough; Tom Newton; Michelle O'Leary; Rachel Pearson; Julie Pickford; Richard Sawyer; Nick J Screaton; Anna Sharman; Maggi Simmons; Elaine Smith; Ben Taylor; Sarah Taylor; Anna Walsham; Angela Watts; James Whittaker; Laura Yarnell; Anthony Threlfall; Phil V Barber; Janet Tonge; Richard Booton
Journal:  Thorax       Date:  2018-11-12       Impact factor: 9.139

10.  Development and validation of an electronic frailty index using routine primary care electronic health record data.

Authors:  Andrew Clegg; Chris Bates; John Young; Ronan Ryan; Linda Nichols; Elizabeth Ann Teale; Mohammed A Mohammed; John Parry; Tom Marshall
Journal:  Age Ageing       Date:  2016-03-03       Impact factor: 10.668
View more
  2 in total

1.  Pathologic and gene expression comparison of CT- screen detected and routinely detected stage I/0 lung adenocarcinoma in NCCN risk-matched cohorts.

Authors:  Eric J Burks; Jiarui Zhang; Travis B Sullivan; Xingyi Shi; Jacob M Sands; Shawn M Regis; Brady J McKee; Andrea B McKee; Sherry Zhang; Hanqiao Liu; Gang Liu; Avrum Spira; Jennifer Beane; Marc E Lenburg; Kimberly M Rieger-Christ
Journal:  Cancer Treat Res Commun       Date:  2021-11-10

2.  Lung cancer and Covid-19: lessons learnt from the pandemic and where do we go from here?

Authors:  Susanne Sarah Maxwell; David Weller
Journal:  NPJ Prim Care Respir Med       Date:  2022-05-30       Impact factor: 3.289
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.